Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Cardiovascular therapeutics Market Research Reports

Titlepublishedprice

Critical Limb Ischemia - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Critical Limb Ischemia forecasted market share for ten years to 2023 seg......"
01-Sep-2016$4950

Dyslipidemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... jective of the Dyslipidemia Report is to understand the market and pipeline status of the drugs around the Dyslipidemia to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline ......"
01-Sep-2016$2000

Arrhythmias-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... ective of the Arrhythmias Report is to understand the market and pipeline status of the drugs around the Arrhythmias to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline str......"
01-Sep-2016$2000

Atrial Fibrillation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... key objective of the Atrial Fibrillation Report is to understand the market and pipeline status of the drugs around the Atrial Fibrillation to explore the generic development opportunities, licensing opportunities and to gain competitive advantage o......"
01-Sep-2016$2000

Atrial Flutter-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... objective of the Atrial Flutter Report is to understand the market and pipeline status of the drugs around the Atrial Flutter to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pip......"
01-Sep-2016$2000

Bacterial Endocarditis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... . A key objective of the Bacterial Endocarditis Report is to understand the market and pipeline status of the drugs around the Bacterial Endocarditis to explore the generic development opportunities, licensing opportunities and to gain competitive ad......"
01-Sep-2016$2000

Atrial Fibrillation - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... rkets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Atrial Fibrillation forecasted market share for ten years to 2023 segmented......"
01-Sep-2016$4950

Chronic Heart Failure - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Chronic Heart Failure forecasted market share for ten years to 2023 segme......"
01-Sep-2016$4950

Congestive Heart Failure (Heart Failure)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... s across the globe. A key objective of the Congestive Heart Failure (Heart Failure) Report is to understand the market and pipeline status of the drugs around the Congestive Heart Failure (Heart Failure) to explore the generic development opportuniti......"
01-Sep-2016$2000

Endocarditis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... jective of the Endocarditis Report is to understand the market and pipeline status of the drugs around the Endocarditis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline ......"
01-Sep-2016$2000